Literature DB >> 15446581

Interferon-gamma expression in periventricular leukomalacia in the human brain.

Rebecca D Folkerth1, Rachael J Keefe, Robin L Haynes, Felicia L Trachtenberg, Joseph J Volpe, Hannah C Kinney.   

Abstract

Periventricular leukomalacia (PVL), the major lesion underlying cerebral palsy in survivors of prematurity, is characterized by focal periventricular necrosis and diffuse gliosis of immature cerebral white matter. Causal roles have been ascribed to hypoxiaischemia and maternal-fetal infection, leading to cytokine responses, inflammation, and oligodendrocyte cell death. Because interferon-gamma (IFN-gamma) is directly toxic to immature oligodendrocytes, we tested the hypothesis that it is expressed in PVL (N = 13) compared to age-adjusted controls (N = 31) using immunocytochemistry. In PVL, IFN-gamma immunopositive macrophages were clustered in necrotic foci, and IFN-gamma immunopositive reactive astrocytes were present throughout the surrounding white matter (WM). The difference in the number of IFN-gamma immunopositive glial cells/high power field (IFN-gamma score, Grades 0-3) between PVL cases (age-adjusted mean 2.59+/-0.25) and controls (age-adjusted mean 1.39+/-0.16) was significant (p<0.001). In the gliotic WM, the IFN-gamma score correlated with markers for lipid peroxidation, but not nitrative stress. A subset of premyelinating (04+) oligodendrocytes expressed IFN-gamma receptors in PVL and control cases, indicating that these cells are vulnerable to IFN-gamma toxicity via receptor-mediated interactions. In PVL, IFN-gamma produced by macrophages and reactive astrocytes may play a role in cytokine-induced toxicity to premyelinating oligodendrocytes as part of a cytokine response stimulated by ischemia and/or infection.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15446581     DOI: 10.1111/j.1750-3639.2004.tb00063.x

Source DB:  PubMed          Journal:  Brain Pathol        ISSN: 1015-6305            Impact factor:   6.508


  34 in total

Review 1.  Pathophysiology of glia in perinatal white matter injury.

Authors:  Stephen A Back; Paul A Rosenberg
Journal:  Glia       Date:  2014-03-31       Impact factor: 7.452

Review 2.  Brain injury in premature infants: a complex amalgam of destructive and developmental disturbances.

Authors:  Joseph J Volpe
Journal:  Lancet Neurol       Date:  2009-01       Impact factor: 44.182

3.  12/15-lipoxygenase expression is increased in oligodendrocytes and microglia of periventricular leukomalacia.

Authors:  Robin L Haynes; Klaus van Leyen
Journal:  Dev Neurosci       Date:  2013-04-20       Impact factor: 2.984

4.  Regulation of neuronal excitability by release of proteins from glial cells.

Authors:  Birte A Igelhorst; Vanessa Niederkinkhaus; Claudia Karus; Maren D Lange; Irmgard D Dietzel
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-07-05       Impact factor: 6.237

Review 5.  Pathogenesis of cerebral palsy through the prism of immune regulation of nervous tissue homeostasis: literature review.

Authors:  Natalya Lisovska; Zholtay Daribayev; Yevgeny Lisovskyy; Kenzhe Kussainova; Lana Austin; Sholpan Bulekbayeva
Journal:  Childs Nerv Syst       Date:  2016-09-14       Impact factor: 1.475

Review 6.  Systemic prenatal insults disrupt telencephalon development: implications for potential interventions.

Authors:  Shenandoah Robinson
Journal:  Epilepsy Behav       Date:  2005-08-02       Impact factor: 2.937

Review 7.  Pathogenesis of cerebral white matter injury of prematurity.

Authors:  O Khwaja; J J Volpe
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2008-03       Impact factor: 5.747

8.  The encephalopathy of prematurity: one pediatric neuropathologist's perspective.

Authors:  Hannah C Kinney
Journal:  Semin Pediatr Neurol       Date:  2009-12       Impact factor: 1.636

Review 9.  The encephalopathy of prematurity--brain injury and impaired brain development inextricably intertwined.

Authors:  Joseph J Volpe
Journal:  Semin Pediatr Neurol       Date:  2009-12       Impact factor: 1.636

Review 10.  Cytokine dysregulation in autism spectrum disorders (ASD): possible role of the environment.

Authors:  Paula E Goines; Paul Ashwood
Journal:  Neurotoxicol Teratol       Date:  2012-08-17       Impact factor: 3.763

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.